We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
-5.2%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$405M
AUM Growth
-$18.1M
Cap. Flow
+$17M
Cap. Flow %
4.2%
Top 10 Hldgs %
67.31%
Holding
51
New
5
Increased
22
Reduced
10
Closed
5

Top Buys

Rank Stock Value
1
CNNE icon
Cannae Holdings
CNNE
+$16.9M
2
TSVT
2seventy bio
TSVT
+$15.3M
3
BVFL icon
BV Financial
BVFL
+$8.71M
4
CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
+$3.15M
5
PAR icon
PAR Technology
PAR
+$3.12M

Top Sells

Rank Stock Value
1
GIII icon
G-III Apparel Group
GIII
+$17.7M
2
ONL
Orion Office REIT
ONL
+$11M
3
AMPY icon
Amplify Energy
AMPY
+$2.66M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
+$2.52M
5
DXLG icon
Destination XL Group
DXLG
+$2.35M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.37%
2 Healthcare 23.68%
3 Communication Services 11.57%
4 Technology 9.35%
5 Financials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECX
26
Tectonic Therapeutic
TECX
$536M
$3.08M 0.76%
+166,667
New +$2.95M
WVE icon
27
Wave Life Sciences
WVE
$1.12B
$2.93M 0.72%
510,000
+10,000
+2% +$45.7K
KOD icon
28
Kodiak Sciences
KOD
$2.5B
$2.9M 0.71%
1,608,694
+618,991
+63% +$2.18M
DXLG icon
29
Destination XL Group
DXLG
$32.9M
$2.69M 0.66%
600,000
-500,000
-45% -$2.35M
ONL
30
Orion Office REIT
ONL
$151M
$2.47M 0.61%
474,721
-1,815,279
-79% -$11M
OLMA icon
31
Olema Pharmaceuticals
OLMA
$977M
$1.85M 0.46%
150,000
-25,000
-14% -$255K
AIV
32
Aimco
AIV
$377M
$1.58M 0.39%
+231,865
New +$1.84M
ADVM
33
DELISTED
Adverum Biotechnologies
ADVM
$1.54M 0.38%
102,500
+2,500
+3% +$44.9K
FTH
34
Faeth Therapeutics
FTH
$746M
$1.35M 0.33%
90,000
-1,362
-1% -$29.3K
LENZ
35
LENZ Therapeutics
LENZ
$179M
$1.35M 0.33%
+77,520
New +$1.35M
AVIR icon
36
Atea Pharmaceuticals
AVIR
$370M
$1.2M 0.3%
400,000
+310,803
+348% +$1.06M
BOLT icon
37
Bolt Biotherapeutics
BOLT
$7.4M
$1.06M 0.26%
51,000
+1,000
+2% +$24.4K
MRSN
38
DELISTED
Mersana Therapeutics
MRSN
$889K 0.22%
+28,000
New +$1.33M
ALGS icon
39
Aligos Therapeutics
ALGS
$26.3M
$687K 0.17%
36,800
+800
+2% +$17.7K
ORKA
40
Oruka Therapeutics
ORKA
$5.31B
$603K 0.15%
25,000
-1,100
-4% -$26.9K
BDTX icon
41
Black Diamond Therapeutics
BDTX
$95.1M
$588K 0.15%
205,000
+5,000
+3% +$18.4K
BRLIR
42
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$95.6K 0.02%
457,409
– –
ARIZR
43
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$22.5K 0.01%
250,000
– –
LFLYW
44
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$19K ﹤0.01%
634,640
– –
VHAQ.RT
45
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$12.8K ﹤0.01%
250,000
– –
AMPY icon
46
Amplify Energy
AMPY
$158M
– –
-393,214
Closed -$2.66M
GBTG icon
47
American Express Global Business Travel
GBTG
$4.92B
– –
-30,923
Closed -$224K
LW icon
48
Lamb Weston
LW
$7.42B
– –
-2,157
Closed -$248K
DBTX
49
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
– –
-200,000
Closed -$770K
PRTK
50
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-764,274
Closed -$1.69M
1
2

Similar funds

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
LJAC
L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return
NI
NetEase Inc Hangzhou, China $934M AUM 11.31% 1-Year Est. Return
MCM
Massar Capital Management Stamford, Connecticut $934M AUM 14.18% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
TW
TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Newtyn Management's Q3 2023 Portfolio in Review

As of Q3 2023, Newtyn Management held 51 positions worth $405M, down 4.3% from $423M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Newtyn Management deployed $17M of net new capital in Q3 2023, opening 5 new positions and adding to 22 existing holdings. Its largest new stake was BV Financial: 879,341 shares worth $8.86M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was G-III Apparel Group, an estimated $17.7M trimmed.

  • Newtyn Management's largest Q3 2023 buy was BV Financial: 879,341 shares worth $8.86M.
  • Newtyn Management added most to Cannae Holdings in Q3 2023, an estimated $16.9M increase.
  • Newtyn Management's biggest Q3 2023 reduction was G-III Apparel Group, cutting an estimated $17.7M.
  • Newtyn Management fully exited Amplify Energy in Q3 2023, selling an estimated $2.66M.
  • Newtyn Management's ten largest holdings make up 67% of its $405M portfolio in Q3 2023.
  • Newtyn Management opened 5 new positions and closed 5 in Q3 2023.
  • Newtyn Management's portfolio value fell 4.3% quarter-over-quarter to $405M.

Based on Newtyn Management's 13F filing for Q3 2023, filed 14 Nov 2023.